Update on Clinical Pharmacology
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Pharmaceutical Science".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 661
Special Issue Editor
Interests: drug delivery system; clinical pharmacology; pharmacokinetics; disease models; new drug development; clinical trials; exosome; clinical toxicology; therapeutic drug monitoring; drug assays method; development in biological fluids
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Clinical pharmacology is a branch of biomedical science that studies the clinical use and effects of drugs on their targets in living systems, along with their discovery, and the biological functions related to these chemicals. This Special Issue, “Update on Clinical Pharmacology”, will feature in Life, an international, peer-reviewed, and open access journal. It aims to cover various aspects of pharmacological applications, such as drug efficacy, drug safety (adverse drug reactions), new drug development, clinical trials, therapeutic drug monitoring, pharmacodynamics, pharmacokinetics, pharmacoeconomics, pharmacovigilance and clinical toxicology. Original research, methodology papers, short reports, reviews and commentaries in all areas of drug experience in humans will be considered.
Prof. Dr. Ju-Seop Kang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug efficacy and drug safety
- new drug development
- therapeutic drug monitoring
- clinical trials
- pharmacodynamic and pharmacokinetics
- pharmacovigilance
- clinical toxicology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
